Envigo testing single wall carbon nanotubes

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Anna Wolska-Rzewuska)
(Image: iStock/Anna Wolska-Rzewuska)
Envigo has collaborated with InterTek and OCSiAl to develop TUBALL™ single wall carbon nanotubes, which is the first of its kind to complete REACH registration.

In the pharmaceutical industry, carbon nanotubes​ are used in drug delivery and biosensing technology. SWNTs specifically, have been shown to improve solubility and efficiency in drug targeting/delivery.

SWCNT are already widely used by organizations that require it to improve their existing products or to create new ones​,” Joseph Bedford, Corporate Vice President, Strategic Marketing, Envigo, told us.

According to the company, OCSiAl is the world's first manufacturer of single wall carbon nanotubes (SWCNT) to complete REACH registration.

In a commercial sense this registration is really important because it’s the first one of its kind and opens up the market for single wall carbon nanotubes to start being used in industrial scales​,” said Bedford.

However, more broadly, Bedford explained the product’s registration will reduce the number of actual materials necessary to create more efficient products.

Bedford said, “This shift to less materials will play a key role in reducing carbon emissions, helping to reduce the degradation of the earth’s biosphere, and empowering people worldwide to raise their standard of living​.”

Moving forward, OSCiAl will test TUBALL for various applications on an ongoing basis with Envigo.

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Related suppliers

Follow us


View more